Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients ...

Another long-term casualty of the state/local funding cuts will likely be recruiting, training, and retaining the expert ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

A rare syndrome linked to purple urine reveals surprising insights into bacterial colonisation, metabolism, and risks for ...

Report’ concludes that the whole class of PFAS, except fluoropolymers, is harmful to human health and the environment.

Adhering to the recommendations should improve psychological well-being, as well as pelvic, musculoskeletal, and ...

While most guidelines require 6 months of behavioral interventions before prescribing weight-loss drugs, new research shows ...

A retrospective review reports that pregnant women with pityriasis rosea onset before 15 weeks have higher rates of ...

A more complete evaluation with 11 variables helps explain why kids may not feel well after they are deemed well by ...

New evidence suggests that factors other than the percentage of weight loss should be considered when determining the success ...

An add-on agent designed to boost drugs that treat age-related macular degeneration failed to show any benefit in two phase 3 ...